Melanoma is a serious type of skin cancer and is ranked the 5th most diagnosed cancer in the United States. Each year, about 331,000 new cases of melanoma are diagnosed worldwide, with roughly 58,000 deaths occurring due to this disease. Depending upon its level of spread, melanoma is broadly classified into 5 stages: 0, 1, 2, 3, and 4. The 5-year survival rate for patients in stage IV melanoma, which is the most advanced stage, is 23%. The global melanoma market, which was valued at $7.2 billion in 2023, is expected to reach more than $13 billion by 2030, according to reports.
The company we are profiling today is IO Biotech (IOBT), which is developing an immune-modulatory, off-the-shelf therapeutic cancer vaccine for melanoma.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.